^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

lacnotuzumab (MCS110)

i
Other names: MCS110, MCS 110, MCS-110
Company:
Novartis
Drug class:
CSF-1 inhibitor